Clinical Trial Update: Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating donor umbilical cord blood transplant after fludarabine phosphate, cyclophosphamide, and total-body irradiation in high-risk hematolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-11-10